SEC Comment Letter for Intersect ENT, Inc. (CIK 0001271214) — Apr 29, 2020
Intersect ENT, Inc. (CIK 0001271214)
Date: April 29, 2020 · CIK: 0001271214 · Accession: 0000000000-20-003687
AI Filing Summary & Sentiment
File numbers found in text: 001-36545
Letter
United States securities and exchange commission logo April 29, 2020 Thomas West Chief Executive Officer Intersect ENT, Inc. 1555 Adams Drive Menlo Park, CA 94025 Re:Intersect ENT, Inc. Preliminary Proxy Statement on Schedule 14A Filed on April 9, 2020 File No. 001-36545 Dear Mr. West: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Brett White, Esq.
Show Raw Text
United States securities and exchange commission logo
April 29, 2020
Thomas West
Chief Executive Officer
Intersect ENT, Inc.
1555 Adams Drive
Menlo Park, CA 94025
Re:Intersect ENT, Inc.
Preliminary Proxy Statement on Schedule 14A
Filed on April 9, 2020
File No. 001-36545
Dear Mr. West:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Brett White, Esq.